{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:51:54Z","timestamp":1792857114160,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["RT3-07893"],"award-info":[{"award-number":["RT3-07893"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["NIA T32 AG00096-30"],"award-info":[{"award-number":["NIA T32 AG00096-30"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["NINDS T32 NS082174-01"],"award-info":[{"award-number":["NINDS T32 NS082174-01"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.neuint.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T23:17:14Z","timestamp":1487632634000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"special_numbering":"C","title":["Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-6945","authenticated-orcid":false,"given":"Samuel E.","family":"Marsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7770-7157","authenticated-orcid":false,"given":"Mathew","family":"Blurton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2017.02.006_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuropsychologia.2014.05.023","article-title":"Greater striatal responses to medication in Parkinson\u05f3s disease are associated with better task-switching but worse reward performance","volume":"62","author":"Aarts","year":"2014","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neuint.2017.02.006_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(89)91678-8","article-title":"Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization","volume":"503","author":"Adem","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2017.02.006_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hipo.22405","article-title":"Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss","volume":"25","author":"Ager","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuint.2017.02.006_bib4","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1523\/JNEUROSCI.21-20-08108.2001","article-title":"Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease","volume":"21","author":"Akerud","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-2236(95)93943-R","article-title":"Genetics and molecular biology of Huntington's disease","volume":"18","author":"Albin","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"Alzheimer\u2019s Association","year":"2016","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.neuint.2017.02.006_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2217\/rme.11.22","article-title":"Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient","volume":"6","author":"Anderson","year":"2011","journal-title":"Regen. Med."},{"key":"10.1016\/j.neuint.2017.02.006_bib100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.stemcr.2016.12.018","article-title":"Preclinical efficacy failure of human CNS-derived stem cells for use in the pathway study of cervical spinal cord injury","volume":"8","author":"Anderson","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuint.2017.02.006_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.conb.2007.03.013","article-title":"Neurotrophins, synaptic plasticity and dementia","volume":"17","author":"Arancio","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuint.2017.02.006_bib9","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's disease after neural transplantation","volume":"356","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2017.02.006_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1750-3639.1991.tb00667.x","article-title":"Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function","volume":"1","author":"Beyreuther","year":"1991","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.neuint.2017.02.006_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuint.2017.02.006_bib13","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.02.006_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1212\/01.WNL.0000130194.84594.96","article-title":"L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia","volume":"63","author":"Bonelli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2017.02.006_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12017-013-8241-2","article-title":"Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease","volume":"15","author":"Cavallucci","year":"2013","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neuint.2017.02.006_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0891-0618(01)00115-6","article-title":"Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain","volume":"21","author":"Chauhan","year":"2001","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuint.2017.02.006_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2009.05229.x","article-title":"Lewy body pathology in fetal grafts","volume":"1184","author":"Chu","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2017.02.006_bib18","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.0904239106","article-title":"Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration","volume":"106","author":"Cicchetti","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.02.006_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ana.24174","article-title":"Mutant huntingtin is present in neuronal grafts in Huntington disease patients","volume":"76","author":"Cicchetti","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2017.02.006_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/288279a0","article-title":"Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa","volume":"288","author":"Davies","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2017.02.006_bib22","first-page":"2","article-title":"Cognitive deficits in Parkinson's disease","volume":"244","author":"Dubois","year":"1997","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","article-title":"Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease","volume":"209","author":"Ebert","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.expneurol.2010.03.005","article-title":"Ex\u00a0vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease","volume":"224","author":"Ebert","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3727\/096368908784423300","article-title":"GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys","volume":"17","author":"Emborg","year":"2008","journal-title":"Cell Transpl."},{"key":"10.1016\/j.neuint.2017.02.006_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-444-59575-1.00008-9","article-title":"Current status of clinical trials of neural transplantation in Parkinson's disease","volume":"200","author":"Evans","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuint.2017.02.006_bib27","doi-asserted-by":"crossref","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology","volume":"97","author":"Freeman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2017.02.006_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.stemcr.2015.09.008","article-title":"Neural stem cells rescue cognitive and motor dysfunction in a transgenic model of dementia with Lewy bodies through a BDNF-dependent mechanism","volume":"5","author":"Goldberg","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuint.2017.02.006_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2017.02.006_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stem.2015.01.018","article-title":"Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease","volume":"16","author":"Hallett","year":"2015","journal-title":"Cell Stem Cell."},{"key":"10.1016\/j.neuint.2017.02.006_bib31","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1523\/JNEUROSCI.0834-10.2010","article-title":"Cell-mediated neuroprotection in a mouse model of human tauopathy","volume":"30","author":"Hampton","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib32","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer's disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2017.02.006_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2017.02.006_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuint.2017.02.006_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuint.2017.02.006_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3940(87)90034-6","article-title":"Region-specific loss of glutamate innervation in Alzheimer's disease","volume":"73","author":"Hardy","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2017.02.006_bib37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archneur.57.6.846","article-title":"Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas","volume":"57","author":"Hock","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2010-100261","article-title":"FK506 reduces amyloid plaque burden and induces MMP-9 in AbetaPP\/PS1 double transgenic mice","volume":"22","author":"Hong","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2017.02.006_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410220110","article-title":"Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone","volume":"22","author":"Hyman","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/350230a0","article-title":"BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra","volume":"350","author":"Hyman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2017.02.006_bib41","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/BRS.0b013e318059afab","article-title":"BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures","volume":"32","author":"Kamei","year":"2007","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.neuint.2017.02.006_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0306-4522(00)00326-2","article-title":"Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system","volume":"100","author":"Kawamoto","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2017.02.006_bib43","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","article-title":"Neural transplantation in Huntington disease: long-term grafts in two patients","volume":"68","author":"Keene","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2017.02.006_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-5728(94)90049-3","article-title":"Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL\/6 mice","volume":"50","author":"Kitamura","year":"1994","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuint.2017.02.006_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11064-011-0592-1","article-title":"BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid \u03b2-induced toxicity in cultured rat septal neurons","volume":"37","author":"Kitiyanant","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2017.02.006_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/exnr.1997.6501","article-title":"Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease","volume":"145","author":"Lapchak","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jez.1401160206","article-title":"Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo","volume":"116","author":"Levi-Montalcini","year":"1951","journal-title":"J.\u00a0Exp. Zool."},{"key":"10.1016\/j.neuint.2017.02.006_bib48","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuint.2017.02.006_bib49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/mds.25378","article-title":"Developing dopaminergic cell therapy for Parkinson's disease\u2013give up or move forward","volume":"28","author":"Lindvall","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2017.02.006_bib50","doi-asserted-by":"crossref","first-page":"20140370","DOI":"10.1098\/rstb.2014.0370","article-title":"Treatment of Parkinson's disease using cell transplantation","volume":"370","author":"Lindvall","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"10.1016\/j.neuint.2017.02.006_bib51","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(88)90950-6","article-title":"Fetal dopamine-rich mesencephalic grafts in Parkinson's disease","volume":"2","author":"Lindvall","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2017.02.006_bib52","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib53","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0306-4522(90)90051-5","article-title":"Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease","volume":"38","author":"Lowe","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2017.02.006_bib54","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-4886(89)90029-0","article-title":"Expression of NGF and NGF receptor mRNAs in the developing brain: evidence for local delivery and action of NGF","volume":"104","author":"Lu","year":"1989","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-4886(03)00037-2","article-title":"Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury","volume":"181","author":"Lu","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrn3505","article-title":"BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases","volume":"14","author":"Lu","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib57","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","article-title":"Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial","volume":"9","author":"Marks","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/alzrt109","article-title":"Examining the mechanisms that link \u03b2-amyloid and \u03b1-synuclein pathologies","volume":"4","author":"Marsh","year":"2012","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neuint.2017.02.006_bib59","series-title":"Neural Stem Cells in Health and Disease","first-page":"439","article-title":"Prospects of neural stem cell therapy for Alzheimer's disease","author":"Marsh","year":"2015"},{"key":"10.1016\/j.neuint.2017.02.006_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.stemcr.2016.12.019","article-title":"HuCNS-SC human NSCs fail to differentiate, form ectopic clusters, and provide no cognitive benefits in a transgenic model of alzheimer\u2019s disease","volume":"8","author":"Marsh","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuint.2017.02.006_bib61","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1523\/JNEUROSCI.16-15-04604.1996","article-title":"Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells","volume":"16","author":"Mart\u00ednez-Serrano","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrn1908","article-title":"The therapeutic potential of neural stem cells","volume":"7","author":"Martino","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease","volume":"56","author":"Masliah","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2017.02.006_bib64","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/jcb.24432","article-title":"Stem cell-based therapy for Huntington's disease","volume":"114","author":"Maucksch","year":"2013","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.neuint.2017.02.006_bib65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cne.20176","article-title":"Human neural stem cell transplants improve motor function in a rat model of Huntington's disease","volume":"475","author":"McBride","year":"2004","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2017.02.006_bib67","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0300-483X(97)00167-4","article-title":"Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat models","volume":"125","author":"Mollison","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.neuint.2017.02.006_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00441-007-0541-0","article-title":"From bench to bed: the potential of stem cells for the treatment of Parkinson's disease","volume":"331","author":"Morizane","year":"2008","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuint.2017.02.006_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuint.2017.02.006_bib70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.02.006_bib71","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jnr.10396","article-title":"Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons","volume":"69","author":"Ostenfeld","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuint.2017.02.006_bib72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib73","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0306-4522(96)00336-3","article-title":"Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage","volume":"75","author":"P\u00e9rez-Navarro","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2017.02.006_bib74","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0306-4522(95)00162-C","article-title":"Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease","volume":"68","author":"Peschanski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2017.02.006_bib75","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neurobiolaging.2009.05.012","article-title":"Beta-Amyloid impairs axonal BDNF retrograde trafficking","volume":"32","author":"Poon","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2017.02.006_bib76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2017.02.006_bib77","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.25853","article-title":"Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective","volume":"29","author":"Robbins","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2017.02.006_bib78","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.nbd.2010.11.014","article-title":"Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice","volume":"41","author":"Rozkalne","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2017.02.006_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009132.pub2","article-title":"Cholinesterase inhibitors for mild cognitive impairment","volume":"9","author":"Russ","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuint.2017.02.006_bib80","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/er.2004-0024","article-title":"The insulin-like growth factor system and its pleiotropic functions in brain","volume":"26","author":"Russo","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuint.2017.02.006_bib81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nbd.2004.01.016","article-title":"Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease","volume":"16","author":"Ryu","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2017.02.006_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2006.05.022","article-title":"Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration","volume":"51","author":"Salehi","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.02.006_bib83","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.02.006_bib84","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuint.2017.02.006_bib85","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuint.2017.02.006_bib86","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0092-8674(91)90396-G","article-title":"The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor","volume":"65","author":"Soppet","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2017.02.006_bib87","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2017.02.006_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2010.07.051","article-title":"Immunolocalization of pro- and mature-brain derived neurotrophic factor (BDNF) and receptor TrkB in the human brainstem and hippocampus","volume":"1354","author":"Tang","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2017.02.006_bib89","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib90","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02740673","article-title":"Maintaining the neuronal phenotype after injury in the adult CNS. Neurotrophic factors, axonal growth substrates, and gene therapy","volume":"10","author":"Tuszynski","year":"1995","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2017.02.006_bib91","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrn988","article-title":"Role of neurotrophins in central synapse formation and stabilization","volume":"3","author":"Vicario-Abej\u00f3n","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2017.02.006_bib92","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.24436","article-title":"Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: a double-blind, randomized, controlled trial","volume":"78","author":"Warren Olanow","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2017.02.006_bib93","doi-asserted-by":"crossref","first-page":"27358","DOI":"10.1038\/srep27358","article-title":"Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for Alzheimer's disease","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2017.02.006_bib94","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuint.2017.02.006_bib95","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2017.02.006_bib96","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12035-014-8640-x","article-title":"Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP\/PS1 double transgenic model of Alzheimer's disease","volume":"50","author":"Zhang","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2017.02.006_bib97","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.stemcr.2016.08.018","article-title":"ESC-derived BDNF-overexpressing neural progenitors differentially promote recovery in Huntington's disease models by enhanced striatal differentiation","volume":"7","author":"Zimmermann","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuint.2017.02.006_bib98","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2017.02.006_bib99","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701861730102X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701861730102X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T18:22:49Z","timestamp":1568830969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019701861730102X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":100,"alternative-id":["S019701861730102X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2017.02.006","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}